337 related articles for article (PubMed ID: 28008229)
1. Design and in vitro/in vivo evaluation of sustained-release floating tablets of itopride hydrochloride.
Ahmed SM; Ahmed Ali A; Ali AM; Hassan OA
Drug Des Devel Ther; 2016; 10():4061-4071. PubMed ID: 28008229
[TBL] [Abstract][Full Text] [Related]
2. Floating matrix dosage form for phenoporlamine hydrochloride based on gas forming agent: in vitro and in vivo evaluation in healthy volunteers.
Xu X; Sun M; Zhi F; Hu Y
Int J Pharm; 2006 Mar; 310(1-2):139-45. PubMed ID: 16413710
[TBL] [Abstract][Full Text] [Related]
3. Design and optimization of gastric floating sustained-release mini-tablets of alfuzosin hydrochloride based on a factorial design: in vitro/in vivo evaluation.
Gong L; Yu M; Sun Y; Gao Y; An T; Zou M; Cheng G
Drug Dev Ind Pharm; 2018 Dec; 44(12):1990-1999. PubMed ID: 30058391
[TBL] [Abstract][Full Text] [Related]
4. Formulation and in vitro, in vivo evaluation of effervescent floating sustained-release imatinib mesylate tablet.
Kadivar A; Kamalidehghan B; Javar HA; Davoudi ET; Zaharuddin ND; Sabeti B; Chung LY; Noordin MI
PLoS One; 2015; 10(6):e0126874. PubMed ID: 26035710
[TBL] [Abstract][Full Text] [Related]
5. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
[TBL] [Abstract][Full Text] [Related]
6. Development and in vivo floating behavior of verapamil HCl intragastric floating tablets.
Patel A; Modasiya M; Shah D; Patel V
AAPS PharmSciTech; 2009; 10(1):310-5. PubMed ID: 19296224
[TBL] [Abstract][Full Text] [Related]
7. Effect of formulation parameters on the drug release and floating properties of gastric floating two-layer tablets with acetylsalicylic acid.
Hasçiçek C; Yüksel-Tilkan G; Türkmen B; Ozdemir N
Acta Pharm; 2011 Sep; 61(3):303-12. PubMed ID: 21945909
[TBL] [Abstract][Full Text] [Related]
8. Tablets compressed with gastric floating pellets coated with acrylic resin for gastro retention and sustained release of famotidine: in-vitro and in-vivo study.
Qi X; Jiang Y; Zhang H; Wu Z
J Pharm Pharmacol; 2015 Apr; 67(4):493-500. PubMed ID: 25495700
[TBL] [Abstract][Full Text] [Related]
9. Preparation and pharmacokinetics study on gastro-floating sustained-release tablets of troxipide.
Gao Y; Gao Y; Yin F; Wang M; Wang Z; Ye T; Yang Y; Pan WS; Yang X
Drug Dev Ind Pharm; 2015; 41(9):1443-51. PubMed ID: 25190152
[TBL] [Abstract][Full Text] [Related]
10. Preparation, Characterization and Evaluation of Flavonolignan Silymarin Effervescent Floating Matrix Tablets for Enhanced Oral Bioavailability.
Ahmad S; Khan JA; Kausar TN; Mahnashi MH; Alasiri A; Alqahtani AA; Alqahtani TS; Walbi IA; Alshehri OM; Elnoubi OA; Mahmood F; Sadiq A
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985575
[TBL] [Abstract][Full Text] [Related]
11. Preparation of multiple-unit floating-bioadhesive cooperative minitablets for improving the oral bioavailability of famotidine in rats.
Zhu X; Qi X; Wu Z; Zhang Z; Xing J; Li X
Drug Deliv; 2014 Sep; 21(6):459-66. PubMed ID: 24456044
[TBL] [Abstract][Full Text] [Related]
12. Floating tablets for controlled release of ofloxacin via compression coating of hydroxypropyl cellulose combined with effervescent agent.
Qi X; Chen H; Rui Y; Yang F; Ma N; Wu Z
Int J Pharm; 2015 Jul; 489(1-2):210-7. PubMed ID: 25956047
[TBL] [Abstract][Full Text] [Related]
13. Development and Optimization of Gastro-Retentive Controlled-Release Tablet of Calcium-Disodium Edentate and its In Vivo Gamma Scintigraphic Evaluation.
Kumar N; Soni S; Singh T; Kumar A; Ahmad FJ; Bhatnagar A; Mittal G
AAPS PharmSciTech; 2015 Dec; 16(6):1270-80. PubMed ID: 25771737
[TBL] [Abstract][Full Text] [Related]
14. Design, development and optimization of sustained release floating, bioadhesive and swellable matrix tablet of ranitidine hydrochloride.
Nigusse B; Gebre-Mariam T; Belete A
PLoS One; 2021; 16(6):e0253391. PubMed ID: 34170952
[TBL] [Abstract][Full Text] [Related]
15. Floating and sustained-release characteristics of effervescent tablets prepared with a mixed matrix of Eudragit L-100-55 and Eudragit E PO.
Bani-Jaber AK; Alkawareek MY; Al-Gousous JJ; Abu Helwa AY
Chem Pharm Bull (Tokyo); 2011; 59(2):155-60. PubMed ID: 21297292
[TBL] [Abstract][Full Text] [Related]
16. Development of Multiple-Unit Floating Drug Delivery System of Clarithromycin: Formulation, in vitro Dissolution by Modified Dissolution Apparatus, in vivo Radiographic Studies in Human Volunteers.
Reddy AB; Reddy ND
Drug Res (Stuttg); 2017 Jul; 67(7):412-418. PubMed ID: 28449156
[TBL] [Abstract][Full Text] [Related]
17. Development of sustained release floating drug delivery system for norfloxacin: in vitro and in vivo evaluation.
Guguloth M; Bomma R; Veerabrahma K
PDA J Pharm Sci Technol; 2011; 65(3):198-206. PubMed ID: 22293231
[TBL] [Abstract][Full Text] [Related]
18. A novel automated alternating current biosusceptometry method to characterization of controlled-release magnetic floating tablets of metronidazole.
Ferrari PC; dos Santos Grossklauss DB; Alvarez M; Paixão FC; Andreis U; Crispim AG; de Castro AD; Evangelista RC; de Arruda Miranda JR
Drug Dev Ind Pharm; 2014 Aug; 40(8):1123-31. PubMed ID: 23815300
[TBL] [Abstract][Full Text] [Related]
19. Formulation and evaluation of effervescent floating tablets of tizanidine hydrochloride.
Someshwar K; Chithaluru K; Ramarao T; Kumar KK
Acta Pharm; 2011 Jun; 61(2):217-26. PubMed ID: 21684848
[TBL] [Abstract][Full Text] [Related]
20. Formulation and optimization of floating matrix tablets of clarithromycin using simplex lattice design.
Singh I; Saini V
Pak J Pharm Sci; 2016 Mar; 29(2):511-9. PubMed ID: 27087096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
